vs

Side-by-side financial comparison of MetroCity Bankshares, Inc. (MCBS) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

MetroCity Bankshares, Inc. is the larger business by last-quarter revenue ($43.7M vs $32.6M, roughly 1.3× RxSight, Inc.). MetroCity Bankshares, Inc. runs the higher net margin — 50.5% vs -28.1%, a 78.6% gap on every dollar of revenue. On growth, MetroCity Bankshares, Inc. posted the faster year-over-year revenue change (23.6% vs -18.9%). MetroCity Bankshares, Inc. produced more free cash flow last quarter ($37.0M vs $-2.3M). Over the past eight quarters, MetroCity Bankshares, Inc.'s revenue compounded faster (15.7% CAGR vs 5.1%).

Metro City Bank is a Korean-American bank based in Doraville, Georgia and offers personal and commercial banking services. It is the largest Korean-American bank to not be based out of Los Angeles, California. It currently operates a total of 19 branches in Texas, New York, New Jersey, Virginia, Georgia, Alabama, and Florida.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

MCBS vs RXST — Head-to-Head

Bigger by revenue
MCBS
MCBS
1.3× larger
MCBS
$43.7M
$32.6M
RXST
Growing faster (revenue YoY)
MCBS
MCBS
+42.5% gap
MCBS
23.6%
-18.9%
RXST
Higher net margin
MCBS
MCBS
78.6% more per $
MCBS
50.5%
-28.1%
RXST
More free cash flow
MCBS
MCBS
$39.3M more FCF
MCBS
$37.0M
$-2.3M
RXST
Faster 2-yr revenue CAGR
MCBS
MCBS
Annualised
MCBS
15.7%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MCBS
MCBS
RXST
RXST
Revenue
$43.7M
$32.6M
Net Profit
$18.1M
$-9.2M
Gross Margin
77.5%
Operating Margin
52.8%
-34.8%
Net Margin
50.5%
-28.1%
Revenue YoY
23.6%
-18.9%
Net Profit YoY
11.7%
-54.1%
EPS (diluted)
$0.69
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCBS
MCBS
RXST
RXST
Q4 25
$43.7M
$32.6M
Q3 25
$38.0M
$30.3M
Q2 25
$37.9M
$33.6M
Q1 25
$36.0M
$37.9M
Q4 24
$35.4M
$40.2M
Q3 24
$36.9M
$35.3M
Q2 24
$36.3M
$34.9M
Q1 24
$32.7M
$29.5M
Net Profit
MCBS
MCBS
RXST
RXST
Q4 25
$18.1M
$-9.2M
Q3 25
$17.3M
$-9.8M
Q2 25
$16.8M
$-11.8M
Q1 25
$16.3M
$-8.2M
Q4 24
$16.2M
$-5.9M
Q3 24
$16.7M
$-6.3M
Q2 24
$16.9M
$-6.1M
Q1 24
$14.6M
$-9.1M
Gross Margin
MCBS
MCBS
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
MCBS
MCBS
RXST
RXST
Q4 25
52.8%
-34.8%
Q3 25
62.8%
-40.1%
Q2 25
62.4%
-41.6%
Q1 25
61.3%
-28.2%
Q4 24
58.9%
-21.5%
Q3 24
61.4%
-26.1%
Q2 24
64.4%
-23.9%
Q1 24
62.6%
-36.2%
Net Margin
MCBS
MCBS
RXST
RXST
Q4 25
50.5%
-28.1%
Q3 25
45.5%
-32.4%
Q2 25
44.4%
-35.0%
Q1 25
45.3%
-21.6%
Q4 24
54.0%
-14.8%
Q3 24
45.3%
-17.9%
Q2 24
46.7%
-17.4%
Q1 24
44.8%
-30.8%
EPS (diluted)
MCBS
MCBS
RXST
RXST
Q4 25
$0.69
$-0.22
Q3 25
$0.67
$-0.24
Q2 25
$0.65
$-0.29
Q1 25
$0.63
$-0.20
Q4 24
$0.64
$-0.14
Q3 24
$0.65
$-0.16
Q2 24
$0.66
$-0.16
Q1 24
$0.57
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCBS
MCBS
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$383.7M
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$544.2M
$275.7M
Total Assets
$4.8B
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCBS
MCBS
RXST
RXST
Q4 25
$383.7M
$228.1M
Q3 25
$227.2M
$227.5M
Q2 25
$286.0M
$227.5M
Q1 25
$285.1M
$229.3M
Q4 24
$249.9M
$237.2M
Q3 24
$291.2M
$237.1M
Q2 24
$327.9M
$233.3M
Q1 24
$258.8M
$125.4M
Stockholders' Equity
MCBS
MCBS
RXST
RXST
Q4 25
$544.2M
$275.7M
Q3 25
$445.9M
$276.0M
Q2 25
$436.1M
$278.0M
Q1 25
$428.0M
$279.3M
Q4 24
$421.4M
$281.2M
Q3 24
$407.2M
$277.3M
Q2 24
$407.2M
$275.2M
Q1 24
$396.6M
$163.9M
Total Assets
MCBS
MCBS
RXST
RXST
Q4 25
$4.8B
$311.8M
Q3 25
$3.6B
$308.5M
Q2 25
$3.6B
$309.0M
Q1 25
$3.7B
$313.0M
Q4 24
$3.6B
$318.6M
Q3 24
$3.6B
$310.5M
Q2 24
$3.6B
$305.5M
Q1 24
$3.6B
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCBS
MCBS
RXST
RXST
Operating Cash FlowLast quarter
$37.7M
$-1.1M
Free Cash FlowOCF − Capex
$37.0M
$-2.3M
FCF MarginFCF / Revenue
84.7%
-6.9%
Capex IntensityCapex / Revenue
1.5%
3.5%
Cash ConversionOCF / Net Profit
2.08×
TTM Free Cash FlowTrailing 4 quarters
$79.4M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCBS
MCBS
RXST
RXST
Q4 25
$37.7M
$-1.1M
Q3 25
$16.5M
$-1.2M
Q2 25
$14.5M
$-4.4M
Q1 25
$11.9M
$-8.8M
Q4 24
$63.5M
$-4.3M
Q3 24
$-11.5M
$650.0K
Q2 24
$19.4M
$-4.0M
Q1 24
$36.4M
$-9.3M
Free Cash Flow
MCBS
MCBS
RXST
RXST
Q4 25
$37.0M
$-2.3M
Q3 25
$16.2M
$-1.8M
Q2 25
$14.3M
$-5.9M
Q1 25
$11.8M
$-9.4M
Q4 24
$62.2M
$-5.1M
Q3 24
$-11.8M
$-453.0K
Q2 24
$19.0M
$-5.5M
Q1 24
$36.1M
$-11.3M
FCF Margin
MCBS
MCBS
RXST
RXST
Q4 25
84.7%
-6.9%
Q3 25
42.7%
-5.8%
Q2 25
37.8%
-17.6%
Q1 25
32.9%
-24.8%
Q4 24
175.8%
-12.7%
Q3 24
-31.9%
-1.3%
Q2 24
52.4%
-15.9%
Q1 24
110.6%
-38.2%
Capex Intensity
MCBS
MCBS
RXST
RXST
Q4 25
1.5%
3.5%
Q3 25
0.7%
1.9%
Q2 25
0.3%
4.6%
Q1 25
0.2%
1.5%
Q4 24
3.6%
2.1%
Q3 24
0.8%
3.1%
Q2 24
1.0%
4.4%
Q1 24
0.7%
6.7%
Cash Conversion
MCBS
MCBS
RXST
RXST
Q4 25
2.08×
Q3 25
0.95×
Q2 25
0.86×
Q1 25
0.73×
Q4 24
3.91×
Q3 24
-0.69×
Q2 24
1.14×
Q1 24
2.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MCBS
MCBS

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons